Federal Register #2026-20144

DEA review of Schedule II prescription partial-fill recordkeeping requirements

The U.S. Drug Enforcement Administration is seeking public comments on continuing recordkeeping requirements for partial fills of Schedule II prescriptions. - Government agency: U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA), Diversion Control Division. - Purpose: Review and possible continuation of an information collection; this is not a procurement opportunity or contract award. - Requirement: Recordkeeping for partial fills of Schedule II controlled-substance prescriptions. - Affected entities and estimated burden: An estimated 66,088 for-profit business registrants, with an estimated 27,149 hours of burden annually and no associated annual cost burden. - OEMs and vendors: None identified. - Products or services requested: None.

Description

The Drug Enforcement Administration (DEA), Department of Justice, is submitting a previously approved information collection for review and approval by the Office of Management and Budget under the Paperwork Reduction Act of 1995. The collection concerns recordkeeping requirements for partial fills of prescriptions for Schedule II controlled substances. The affected public is for-profit businesses, with an estimated 66,088 registrants and an annual burden of 27,149 hours. Comments are due November 2, 2026.

View original listing